GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval dlvr.it/TJ1njL #News #Regulatory #FDA

“We’ve really hit our stride over the last couple of years in terms of new companies being born out of academic labs, and otherwise getting funding and starting in Connecticut,” CBIA's Paul Pescatello tells Hartford Business about #Connecticut’s #bioscience industry. hartfordbusiness.com/article/despit…

CBIA Bioscience Growth Council’s Paul Pescatello joined patients, advocates, policymakers, and industry leaders to highlight #RareDiseaseDay2025—raising awareness about these life-changing conditions and the #research and #innovation underway to improve the lives of patients and families.

FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog fiercepharma.com/pharma/fda-sig…

‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD cardiovascularbusiness.com/topics/cardiac…

AstraZeneca’s Imfinzi regimen approved by FDA to treat bladder cancer dlvr.it/TJtJPq #News #Regulatory #AstraZeneca

#NEWS:Arvinas Presents First-in-Human Data for Investigational Oral novel PROTAC LRRK2 Degrader Demonstrating Blood-Brain Barrier Penetration, and Central and Peripheral LRRK2 Degradation. Read More: bit.ly/4hXSctC

Boehringer Ingelheim, Cue Biopharma Partner to Commercialize Therapy for Immune Diseases contractpharma.com/breaking-news/…

🎙️Out now! The bonus episodes of Science Will Win Season 4 recorded at SXSW are live! Hear how digital tools are empowering patients & how teamwork is key in the fight to out do cancer. Tune in on your favorite podcast app! 🎧 on.pfizer.com/42g1QmR

Medtronic sends Hugo robot in for FDA review with urologic study success fiercebiotech.com/medtech/medtro…

hartfordbusiness.com/article/ct-inn…

Health Rounds: Boehringer Ingelheim drug delivers 'unprecedented' result in lung cancer study msn.com/en-us/health/o…

The U.S. FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the drug in the fourth quarter of this year. #FDA #GLP1 #wegovy #biospace hubs.li/Q03l1wT70

Sanofi to acquire Vigil Neuroscience in $470 million deal to boost neurological pipeline reuters.com/markets/deals/…

“#Innovation isn’t just technology, robots, and hardware,” Chris DiPentima tells WTNH News 8's Mike Cerulli and WICC's Melissa Sheketoff on MADE Conversations about how businesses innovate in areas like employee #engagement and #workplace culture. bit.ly/4mIPJqI

Well-deserved recognition for Branford-based ViiV Healthcare US, honored by Governor Ned Lamont for its global efforts to end HIV/AIDS. ViiV's cutting-edge research is at the forefront in the battle to end HIV, helping create 17 medications used by thousands of people across the globe.

“We’ve got to tell the story about a difference that we’re making in people’s lives,” Governor Ned Lamont said during a visit to CBIA member ViiV Healthcare US honoring the company’s growth and breakthroughs in HIV treatment. ctinsider.com/business/artic… #research #innovation #Connecticut

ASCO: Pfizer, chasing full approval conversion for Braftovi combo, touts 'unprecedented' survival win fiercepharma.com/pharma/asco-pf…

J&J Johnson & Johnson Innovation ties early-stage lymphoma CAR-T to 100% response rate in 10 patients fiercebiotech.com/biotech/jj-hai…

Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 fiercebiotech.com/biotech/amgens…